Idorsia to Advance Daridorexant Development in Autism Spectrum Disorder
Idorsia said findings from a Phase 2 pediatric insomnia study support advancing daridorexant development in autism spectrum disorder.
Idorsia said findings from a Phase 2 pediatric insomnia study support advancing daridorexant development in autism spectrum disorder.